Drugs / H077
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07146386 | Aug 2025 → Jan 2027 expected | benign prostatic hyperplasia | Shanghai Huilun Pharmaceutical Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H077 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07146386 ↗ |
| Route | Oral | “orally once daily” NCT07146386 ↗ |